Literature DB >> 5956319

Composition of and physiopathology produced by plague endotoxins.

R V Walker, M G Barnes, E D Higgins.   

Abstract

Mesh:

Substances:

Year:  1966        PMID: 5956319     DOI: 10.1038/2091246a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  7 in total

1.  Mitogenic response of mouse spleen cells and gelation of limulus lysate by lipopolysaccharide of Yersinia pestis and evidence for neutralization of lipopolysaccharide by polymyxin B.

Authors:  T Butler; G Möller
Journal:  Infect Immun       Date:  1977-11       Impact factor: 3.441

2.  Studies on the pathogenesis of plague. Blood coagulation and tissue responses of Macaca mulatta following exposure to aerosols of Pasteurella pestis.

Authors:  M J Finegold; J J Petery; R F Berendt; H R Adams
Journal:  Am J Pathol       Date:  1968-07       Impact factor: 4.307

3.  Pneumonic plague in monkeys. An electron microscopic study.

Authors:  M J Finegold
Journal:  Am J Pathol       Date:  1969-02       Impact factor: 4.307

4.  Chemical and physical properties of lipopolysaccharide of Yersinia pestis.

Authors:  J L Hartley; G A Adams; T G Tornabene
Journal:  J Bacteriol       Date:  1974-06       Impact factor: 3.490

5.  Modification of the structure and activity of lipid A in Yersinia pestis lipopolysaccharide by growth temperature.

Authors:  Kazuyoshi Kawahara; Hiroko Tsukano; Haruo Watanabe; Buko Lindner; Motohiro Matsuura
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

6.  Isolation and Biological Characterization of Pasteurella pestis Endotoxin.

Authors:  J M Albizo; M J Surgalla
Journal:  Infect Immun       Date:  1970-09       Impact factor: 3.441

7.  Activation of Heme Oxygenase Expression by Cobalt Protoporphyrin Treatment Prevents Pneumonic Plague Caused by Inhalation of Yersinia pestis.

Authors:  Joshua L Willix; Jacob L Stockton; Rachel M Olson; Paul E Anderson; Deborah M Anderson
Journal:  Antimicrob Agents Chemother       Date:  2020-03-24       Impact factor: 5.191

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.